Showing results (471-480 of 492) with videos related to

Sort By:
Pageof 50
Plos One|February 9, 2019
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitisKi-Ho Park, Dong Youn Kim, Yu-Mi Lee, et al.
The Korean Journal of Internal Medicine|April 9, 2016
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapyTark Kim, Yu-Mi Lee, Sang-Oh Lee, et al.
Annals of Hematology|June 29, 2013
The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in KoreaJin Seok Kim, June-Won Cheong, Yeo-Kyeoung Kim, et al.
Viruses|November 27, 2021
Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19Seongman Bae, Ji Yeun Kim, So Yun Lim, et al.
Critical Care Medicine|September 15, 2012
Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*Dae Won Park, Byung-Chul Chun, Soon-Sun Kwon, et al.
Viruses|December 28, 2021
Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia Syndrome in KoreaJi-Soo Kwon, Sol Jin, Ji-Yeun Kim, et al.
Leukemia Research|September 2, 2008
Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogeneticsHo Sup Lee, Je-Hwan Lee, Eun-Hye Hur, et al.
Cancer Research and Treatment|September 14, 2016
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast CancerIn Hae Park, Joo Hyuk Sohn, Sung Bae Kim, et al.
The Korean Journal of Internal Medicine|December 14, 2017
No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndromeSang Kyun Sohn, Joon Ho Moon, In Hee Lee, et al.
Annals of Hematology|March 28, 2014
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry studySukjoong Oh, Dong Hoe Koo, Min-Jung Kwon, et al.
Pageof 50